Profile for estimating risk of heart failure

Archives of Internal Medicine

Volumn 159, Issue 11, 1999, Pages 1197-1204

  Kannel, William B ^a   D'Agostino, Ralph B ^a   Silbershatz, Halit ^a   Belanger, Albert J ^a   Wilson, Peter W F ^a,b   Levy, Daniel ^a,b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CARDIOMEGALY; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; ELECTROCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART RATE; HIGH RISK POPULATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK ASSESSMENT; SCORING SYSTEM; SYSTOLIC BLOOD PRESSURE; THORAX RADIOGRAPHY; VALVULAR HEART DISEASE; VITAL CAPACITY;

AGED; AGED, 80 AND OVER; CORONARY DISEASE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEART FAILURE, CONGESTIVE; HEART VALVE DISEASES; HUMANS; HYPERTENSION; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PROGNOSIS; RISK; RISK FACTORS;

EID: 0033553875     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.159.11.1197     Document Type: Article

References (14)

1. Kannel WB, Ho KKL, Thom T. Changing epidemiologic features of cardiac failure. Br Heart J. 1994;72(2 suppl):53-59.
2. Ho KKL, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol. 1993;22(4 suppl A):6A-13A.
3. Ho KKL, Anderson KM, Kannel WB, Grossman W, Levy D. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation. 1993;88:107-115.
4. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med. 1992;327:685-691.
5. Cupples LA, D'Agostino RB. The Framingham Study: Section 35: An Epidemiologic Investigation of Cardiovascular Disease: Survival Following Initial Cardiovascular Events: 30 Year Follow-up. Bethesda, Md: National Heart, Lung, and Blood Institute, US Dept of Health and Human Services; 1988. Publication NIH 88-2969.
6. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham Study. N Engl J Med. 1971;285: 1441-1446.
7. Dawber TR, Meadors GF, Moore FE. Epidemiologic approaches to heart disease: the Framingham Study. Am J Public Health. 1951;41:279-286.
8. Dawber TR, Kannel WB, Lyell LP. An approach to longitudinal studies in a community: the Framingham Study. Ann N Y Acad Sci. 1963;107:539-556.
9. Cox DR. Regression models and life tables. J Stat Soc (B). 1972;34:187-220.
10. Report of the Task Force on Research in Heart Failure. Rockville, Md: National Heart, Lung, and Blood Institute, US Dept of Health and Human Services; 1994.
11. Leavit KR, Lazenby HC, Cowan CA, Letschy SW. National health and expenditures 1990. Health Care Financ Rev. 1991;13:29-54.
12. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure. N Engl J Med. 1991; 325:293-302.
13. Pfeffer MA, Lamas GA, Vaughan DE, Parisi AF, Braunwald E. Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. N Engl J Med. 1988;319:80-86.
14. Pfeffer MA, Braunwald E, Moye LA, et al. Effect of captopril on morbidity and mortality in patients with left ventricular dysfunction after myocardial infarction: results of the survival and left ventricular enlargement trial: the SAVE Investigators. N Engl J Med. 1992;327:669-677.